Comorbid conditions are common in people with multiple sclerosis (MS) and can lead to diagnostic delay and poorer outcomes. Neurologists have an opportunity to identify and address comorbidities within routine care, without major time or resource burden. This review discusses modifiable comorbidities in MS – focusing on hypertension, dyslipidaemia, diabetes, and osteoporosis—highlighting their impact and potential intervention
